The influence of parasitism on the pharmacokinetics of moxidectin in lambs

被引:33
作者
Lespine, A
Sutra, JF
Dupuy, J
Alvinerie, M
Aumont, G
机构
[1] INRA, Lab Pharmacol Toxicol, F-31931 Toulouse 9, France
[2] INRA Tours, Dept Sante Anim, F-37380 Nouzilly, France
关键词
D O I
10.1007/s00436-004-1084-x
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Most pharmacokinetic studies on anthelmintic drugs have been performed on non-parasitized animals. However, it seems likely that the parasite burden could influence the deposition of such drugs. The pharmacokinetics of moxidectin administered orally and by subcutaneous injection was compared in lambs exposed to nematode infection and in parasite naive lambs. Plasma samples were analyzed for moxidectin over 40 days post-treatment. The main pharmacokinetic parameters calculated demonstrated a significant change in drug deposition in infected lambs when compared to controls. The area under the plasma concentration-time curve was decreased 54% and 46% by infection in the subcutaneous and oral groups, respectively. There was also a major decrease in the mean residence time in parasitized lambs. In parallel, the clearance of the drug was increased by infection. Thus, parasite infection dramatically influences the disposition of moxidectin in lambs. These results may contribute to determining a therapeutic strategy adapted to heavily infested animals.
引用
收藏
页码:121 / 126
页数:6
相关论文
共 27 条
[1]   DETERMINATION OF MOXIDECTIN IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH AUTOMATED SOLID-PHASE EXTRACTION AND FLUORESCENCE DETECTION [J].
ALVINERIE, M ;
SUTRA, JF ;
BADRI, M ;
GALTIER, P .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1995, 674 (01) :119-124
[2]   Enhanced plasma availability of moxidectin in fasted horses [J].
Alvinerie, M ;
Sutra, JF ;
Cabezas, I ;
Rubilar, L ;
Perez, R .
JOURNAL OF EQUINE VETERINARY SCIENCE, 2000, 20 (09) :575-578
[3]  
ASATO G, 1990, Patent No. 4916
[4]   EFFECT OF EARLY TREATMENT WITH RAFOXANIDE ON ANTIPYRINE CLEARANCE IN SHEEP INFECTED WITH FASCIOLA-HEPATICA [J].
BENCHAOUI, HA ;
MCKELLAR, QA .
XENOBIOTICA, 1993, 23 (04) :439-448
[5]   COMPARISON OF HEPATIC AND EXTRAHEPATIC DRUG-METABOLIZING ENZYME-ACTIVITIES IN RATS GIVEN SINGLE OR MULTIPLE CHALLENGE INFECTIONS WITH FASCIOLA-HEPATICA [J].
BIROSAUVEUR, B ;
EECKHOUTTE, C ;
BAEZA, E ;
BOULARD, C ;
GALTIER, P .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 1995, 25 (10) :1193-1200
[6]   The effects of body composition on the pharmacokinetics of subcutaneously injected ivermectin and moxidectin in pigs [J].
Craven, J ;
Bjorn, H ;
Hennessy, DR ;
Friis, C .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2002, 25 (03) :227-232
[7]   In vitro metabolism of 14C-moxidectin by hepatic microsomes from various species [J].
Dupuy, J ;
Escudero, E ;
Eeckhoutte, C ;
Sutra, JF ;
Galtier, P ;
Alvinerie, M .
VETERINARY RESEARCH COMMUNICATIONS, 2001, 25 (05) :345-354
[8]   Comparative pharmacokinetics of ivermectin after its subcutaneous administration in healthy sheep and sheep infected with mange [J].
Echeverría, J ;
Mestorino, N ;
Errecalde, JO .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2002, 25 (02) :159-160
[9]   DECREASE IN ALBENDAZOLE SULFONATION DURING EXPERIMENTAL FASCIOLIASIS IN SHEEP [J].
GALTIER, P ;
ALVINERIE, M ;
PLUSQUELLEC, Y ;
TUFENKJI, AE ;
HOUIN, G .
XENOBIOTICA, 1991, 21 (07) :917-924
[10]  
Hennessy DR, 2000, J VET PHARMACOL THER, V23, P203, DOI 10.1046/j.1365-2885.2000.t01-2-00286.x